LGLAX | VIGRX | LGLAX / VIGRX | |
Total Expense Ratio | 0.90 | 0.17 | 529% |
Annual Report Gross Expense Ratio | 0.90 | 0.17 | 529% |
Fund Existence | 14 years | 33 years | - |
Gain YTD | 15.707 | 12.580 | 125% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1500 | 3000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.9B | 324B | 2% |
Annual Yield % from dividends | 0.00 | 0.32 | - |
Returns for 1 year | 36.62 | 24.03 | 152% |
Returns for 3 years | 75.02 | 73.68 | 102% |
Returns for 5 years | 38.66 | 107.20 | 36% |
Returns for 10 years | 127.47 | 321.50 | 40% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSMEX | 59.74 | 0.38 | +0.64% |
Fidelity Select Medical Tech and Devcs | |||
GRSPX | 26.41 | -0.01 | -0.04% |
Cromwell Greenspring Mid Cap Instl | |||
BRWVX | 28.10 | -0.06 | -0.21% |
MFS Blended Research Growth Eq R6 | |||
VSCIX | 117.86 | -0.44 | -0.37% |
Vanguard Small Cap Index I | |||
PMFMX | 23.13 | -0.14 | -0.60% |
Principal MidCap S&P 400 Index R3 |